Q4 2024 Earnings Call Transcript February 20, 2025 Ardelyx, Inc. reports earnings inline with expectations. Reported EPS is ...

(THE CONVERSATION) Medicare Advantage – the commercial alternative to traditional Medicare – is drawing down federal health care funds, costing taxpayers an extra 22% per enrollee to the tune of US$83 ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this year.

Q4 2024 Earnings Call Transcript February 18, 2025 Tactile Systems Technology, Inc. beats earnings expectations. Reported EPS is $0.397, expectations were $0.31. Operator: Please standby. Welcome, ...

However, with the FDA approvals of Wegovy for cardiovascular benefits, plus Ozempic for ... US channel mix across the portfolio is 50% commercial, 30% Medicare and 10% Medicaid and 10% other ...

Insurers will continue to grapple with medical costs in excess of reimbursement rates for Medicare Advantage and Medicaid, while commercial coverage also faces continued high medical costs.

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...